ALPHA TRIBE

Themis Medicare LimitedBoard Meeting, 13-11-2025: Outcome of Board Meeting

13-11-2025 | 01:24 pm

Themis Medicare's board approved Q2 & H1 results, reporting a consolidated loss of ₹3.62 Cr (Q2) and ₹17.84 Cr (H1). The company also withdrew its merger scheme with Gujarat Themis Biosyn, opting to focus on its core domestic formulations business.

No comments yet. Be the first to comment!

All announcements from Themis Medicare Limited